Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison*
| Autor: | Ole Bayer, Yasser Sakr, Michael Bauer, Konrad Reinhart, Bjoern Kabisch, Niels C. Riedemann, Matthias Kohl, Utz Settmacher, Khosro Hekmat, Christiane S. Hartog |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
medicine.medical_specialty Resuscitation medicine.medical_treatment Plasma Substitutes Hydroxyethyl starch Critical Care and Intensive Care Medicine law.invention Cohort Studies Hydroxyethyl Starch Derivatives Interquartile range law Sepsis Intensive care medicine Humans Renal Insufficiency Renal replacement therapy Aged Retrospective Studies Aged 80 and over business.industry Incidence Acute kidney injury Crystalloid Solutions Middle Aged medicine.disease Intensive care unit Surgery Anesthesia Fluid Therapy Gelatin Female Isotonic Solutions business Kidney disease medicine.drug |
| Zdroj: | Critical Care Medicine. 39:1335-1342 |
| ISSN: | 0090-3493 |
| DOI: | 10.1097/ccm.0b013e318212096a |
| Popis: | Objectives: Hydroxyethyl starch 200 is associated with renal impairment in sepsis, but hydroxyethyl starch 130/0.4 and gelatin are considered to be less harmful. We hypothesized that fluid therapy with only crystalloids would decrease the incidence of acute kidney injury. Design: Prospective sequential comparison during intensive care unit stay. Setting: Surgical intensive care unit. Patients: Patients with severe sepsis. Interventions: Changes in standard fluid therapy, with predominantly 6% hydroxyethyl starch from January 2005 to June 2005, 4% gelatin from January 2006 to June 2006, and only crystalloids from September 2008 to June 2009. Measurements and Main Results: Acute kidney injury was defined by the presence of at least one RIFLE class; 118 patients received hydroxyethyl starch, 87 patients received gelatin, 141 patients received only crystalloids. Baseline serum creatinine values were similar. Patients received median cumulative doses of 46 (interquartile range, 18–92) mL/kg hydroxyethyl starch and 43 (interquartile range, 18–76) mL/kg gelatin. Total median fluid amounts were 649 (interquartile range, 275–1098) mL/kg in the hydroxyethyl starch group, 525 (237–868) mL/kg in the gelatin group, and 355 (173–911) mL/kg in the crystalloid group. The difference was statistically significant for hydroxyethyl starch after adjustment for multiple testing. Mean daily fluid intake and fluid balance were higher on days 0 and 1 in the crystalloid group. Acute kidney injury occurred in 70% of patients receiving hydroxyethyl starch (adjusted p = .002) and in 68% of patients receiving gelatin (adjusted p = .025) vs. 47% patients receiving crystalloids. Need for renal replacement therapy tended to be higher in the hydroxyethyl starch group (34%; adjusted p = .086) and in the gelatin group (34%; adjusted p = .162) in comparison to the crystalloid group (20%). Intensive care unit and hospital mortality were similar in each group (hydroxyethyl starch: 35% and 43%; gelatin: 26% and 31%; crystalloids: 30% and 37%). Conclusion: Fluid resuscitation with only crystalloids was equally effective, resulted in a more positive fluid balance only on the first 2 days, and was associated with a lesser incidence of acute kidney injury. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|